Physician profile
William Duncan
NPI 1679516231
$8,642.91
in general payments reported to CMS, 2019-2025
9 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $1,375 · 2021: $1,355 · 2022: $3,607 · 2023: $1,332 · 2024: $270 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Travel and Lodging: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.20 |
| Travel and Lodging | $838.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $6,010.84 | 2020-2025 | |
| Stryker Corporation | $1,570.96 | 2019-2025 | Tornier Perform Reversed Augmented Glenoid, Triathlon, Mako |
| Arthrex, INC. | $389.20 | 2023-2025 | |
| Vericel Corporation | $196.06 | 2020-2024 | Maci |
| Smith+Nephew, INC. | $182.54 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Zimmer Biomet Holdings, INC. | $105.45 | 2019 | |
| Pacira Therapeutics, INC. | $95.34 | 2020-2021 | |
| Innovation Technologies INC | $79.33 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $13.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.